Where can I buy trabectedin Yondelis for advanced liposarcoma in China?

The active ingredient of trabectedin yondelis is trabectedin, which binds to guanine in the small grooves of the DNA, forming complexes and causing its helix to bend into the greater grooves, this binding induces a series of initiating reactions in DNA, affecting multiple transcriptional factors, DNA repair pathways, thereby interfering with the cell cycle and leading to cell death. The drug is not yet available in the Mainland, but has been introduced into clinical trials in Hong Kong**, and patients can choose to make an appointment through Adventist Health and go to Hong Kong to see a doctor for use.

Friends, don't use the medicine for the disease indiscriminately, if it's a prescription drug, you can only get it at the pharmacy of a large hospital.

Trabectedin binds to guanine in the DNA groove, forming a complex and causing its helix to bend into the greater groove, which induces a series of activation responses in DNA, affecting multiple transcriptional factors, DNA repair pathways, thereby interfering with the cell cycle and leading to cell death. It has been approved by the FDA for patients with unresectable advanced liposarcoma and leiomyosarcoma following anthracyclines**. At present, it has been introduced by Hong Kong, and the specific process fee can be done in Hong Kong, and the health pre-assessment can be done.

The EU study enrolled a total of 266 patients with advanced or metastatic liposarcoma versus advanced or metastatic leiomyosarcoma, all of whom had previously received anthracycline and ifosfamide** and had failed**. The study compared doses in two groups, one group three times a month and the other group once every three weeks. The results showed that patients who were given the dose once every 3 weeks had a mean progression-free period of months, and those who were given the dose once a month were months.

In the U.S., patients with metastatic or ** leiomyosarcoma or liposarcoma had an average of about one month of progression-free survival in the trabectedin** group compared to only one month in the dacarbazine** group.

Trabectedin is an alkylating agent and a new non-platinum apoptosis inducer for patients with unresectable or metastatic liposarcoma or leiomyosarcoma receiving a previous anthracycline-containing regimen**. Trabectedin has not yet been listed in the mainland, but it has been sold in Hong Kong, and you can consider buying it through formal channels.

According to the drug report provided by Adventist Health, trabectedin Yondelis is already available for purchase in Hong Kong. On October 23, 2015, the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin), a chemotherapy treatment for specific soft tissue sarcoma (STS)** liposarcoma and leiomyosarcoma that cannot be surgically removed) or advanced (metastasized). This ** was approved for patients who had previously received anthracycline-containing chemotherapy.

For specific information about the effects of trabectedin**leiomyosarcoma, consult your doctor.

Trabectedin is also known as ECTEINASCIDIN 743 or ET-743 under the brand name Yondelis. It is approved for use in Europe, Russia and South Korea for advanced soft tissue sarcoma. The European Commission and the U.S. Food and Drug Administration (FDA) have granted orphan drug status to Betti soft tissue sarcoma and ovarian cancer.

The article mentions that the U.S. study showed that for metastatic or ** leiomyosarcoma or liposarcoma, on average, patients in the Yondelis (trabectedin)** group had a progression-free survival of about one month, compared with only one month of progression-free survival in the dacarbazine (dacarbazine)** group.

Trabatedine yondelis binds to guanine in the DNA groove to form a complex and causes its helix to bend into the groove, and this binding induces a series of activation responses in DNA, affecting multiple transcriptional factors, DNA repair pathways, thereby interfering with the cell cycle and leading to cell death. The drug has been introduced in Hong Kong, and the specific process cost can be used for the preliminary assessment of Hong Kong Security Health.

Doing so is a very good benefit.

Domestic friends can go to the Hong Kong Huate Pharmacy for consultation, and know that the standard of asking questions is to encourage everyone to be objective, concise, clear and standardized, and prohibit meaninglessness. Hopefully so.

If you are in China, you will have it in Hong Kong. You can look for it at a pharmacy in Hong Kong.

Liposarcoma is the second most common soft tissue sarcoma. Histologically poorly differentiated patients had 30% to 40% metastasis, while well-differentiated patients had less metastasis. Although metastasis to the liver, bone marrow, and central nervous system can also occur, the lungs are the most common sites of metastasis.

If it is not in the advanced stage, it is okay to conservatively treat traditional Chinese medicine, and the liposarcoma effect of Beijing Guotai Hospital is good, you can check it online now, and if you think it is reliable, you can go to the hospital to see, of course, if you only believe in Western medicine, then I didn't say it

It depends on the patient's mentality! If she has a better attitude, she can live for a while longer, and if she doesn't know herself, she should be able to live for more than a few months!

Keep your mindset well, the most important thing is mindset.